Benlysta 49401-0102

Generic: Belimumab

Product NDC

49401-0102

Manufacturer: Glaxosmithkline Llc
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: March 10, 2011
Listing Expires: December 31, 2027
Application: BLA125370

Need to source Benlysta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Belimumab	400 mg/5mL

Drug Class

B Lymphocyte Stimulator-specific Inhibitor [EPC]B Lymphocyte Stimulator-directed Antibody Interactions [MoA]B Lymphocyte Stimulator-specific Inhibitor [EPC]

Packaging Options(1)

49401-0102-01

1 VIAL in 1 CARTON (49401-102-01) / 5 mL in 1 VIAL

View →